[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349261-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349261-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-tyro3-attenuates-apoptotic-cell-driven-cancer-stemness-in-triple-negative-breast-cancer","Targeting TYRO3 attenuates apoptotic cell-driven cancer stemness in triple negative breast cancer","","Apoptosis is a common component of the tumor microenvironment, shaped by both rapid turnover in high-grade tumors and chemotherapy. While apoptotic cells can paradoxically support cancer survival and relapse, their mechanisms in triple-negative breast cancer (TNBC) remain unclear. This study shows that aggressive breast cancer cells use TYRO3, a PS-sensing receptor, to interact with apoptotic cells. Apoptotic cell–activated TYRO3 enhances stem-like traits and promotes recurrence via YAP nuclear translocation, and TYRO3 inhibition suppresses these effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-tyro3-attenuates-apoptotic-cell-driven-cancer-stemness-in-triple-negative-breast-cancer/349261/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-tyro3-attenuates-apoptotic-cell-driven-cancer-stemness-in-triple-negative-breast-cancer/349261.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does TYRO3 play in TNBC exposed to apoptotic cells?","Question",{"text":63,"@type":64},"Apoptotic cells activate TYRO3 in aggressive breast cancer cells, enhancing stem-like properties and promoting tumor recurrence. The interaction is mediated through TYRO3 as a phosphatidylserine (PS)-sensing receptor.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study assess cancer stemness after TYRO3 activation?",{"text":68,"@type":64},"Stemness markers NANOG and OCT4 were measured by immunoblotting and quantitative PCR. Functional validation used spheroid formation assays, with additional analysis of YAP nuclear translocation.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism connects TYRO3 activation to stemness induction?",{"text":72,"@type":64},"TYRO3 activation triggers YAP nuclear translocation. YAP knockdown suppressed the stemness-inducing effect, indicating the TYRO3/YAP signaling axis is responsible.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349261,1790226811,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Tran et al. Cell Communication and Signaling (2026) 24:333  \n[https://doi.org/10.1186/s12964-026-02896-y](https://doi.org/10.1186/s12964-026-02896-y)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nTargeting TYRO3 attenuates apoptotic cell– driven cancer stemness in triple negative breast cancer  \nPhuong ThaoTran1, Wan Seob Shim1, Won-Cheol Jeong2, Jaewoo Park1, Myung Jun Kim 1, Seungseok Oh1, Yong June Choi1,3, Munkyung Choi1, Miso Park2* and Keon Wook Kang1*  \nAbstract  \nBackground Apoptosis is a prevalent feature of the tumor microenvironment, driven not only by the rapid cellular turnover of high-grade cancers but also by chemotherapeutic agents. Although accumulating apoptotic cells can paradoxically support cancer cell survival and contribute to tumor recurrence, the roles of apoptotic cells in triplenegative breast cancer (TNBC) have not been elucidated. TYRO3, a receptor tyrosine kinase frequently overexpressed in cancers, plays a pivotal role in malignant progression. Here, we demonstrate that aggressive breast cancer cells exploit TYRO3 as a phosphatidylserine (PS)–sensing receptor to interact with apoptotic cells.  \nMethods We investigated whether apoptotic cell–induced TYRO3 activation promotes cancer stemness. Expression of stemness markers NANOG and OCT4 was evaluated by immunoblottings and quantitative polymerase-chainreaction, and spheroid formation assays were performed to functionally validate stemness. YAP nuclear translocation upon TYRO3 activation was assessed by nuclear fractionation, confocal microscopy, and dual-luciferase reporter assay. To validate the functional role of the TYRO3/YAP signaling axis, TYRO3 andYAP knockdown models were established by CRISPR/Cas9 or retroviral system. The anti-tumor efficacy of KRCT87, a selective TYRO3 inhibitor, was assessed in mouse models of tumor recurrence and tumor formation.  \nResults Apoptotic cells activated TYRO3 in aggressive breast cancer cells, enhancing stem-like properties and promoting tumor recurrence. Co-culture with apoptotic cells enhanced spheroid formation and upregulated stemness markers inTNBC cells, which were abolished by TYRO3 knockdown. Mechanistically, TYRO3 activation led to YAP nuclear translocation, which was responsible for stemness induction, as YAP knockdown suppressed this effect. In vivo xenograft studies demonstrated that TYRO3 inhibition suppressed tumor recurrence and apoptotic cells-induced tumor formation.  \nConclusions Our findings indicate that apoptotic cells in the tumor microenvironment enhance cancer cell stemness and facilitate recurrence through TYRO3 activation. Neoadjuvant treatment with a TYRO3 inhibitor may represent a promising strategy to prevent breast cancer relapse.  \n*Correspondence:  \nMiso Park [miso.park@kangwon.ac.kr](miso.park@kangwon.ac.kr)[ ](miso.park@kangwon.ac.kr)Keon Wook Kang [kwkang@snu.ac.kr](kwkang@snu.ac.kr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://crea","cbCaioU7veNkMypt","https://ap.wps.com/l/cbCaioU7veNkMypt","pdf",9738088,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What role does TYRO3 play in TNBC exposed to apoptotic cells?\",\"answer\":\"Apoptotic cells activate TYRO3 in aggressive breast cancer cells, enhancing stem-like properties and promoting tumor recurrence. The interaction is mediated through TYRO3 as a phosphatidylserine (PS)-sensing receptor.\"},{\"question\":\"How did the study assess cancer stemness after TYRO3 activation?\",\"answer\":\"Stemness markers NANOG and OCT4 were measured by immunoblotting and quantitative PCR. Functional validation used spheroid formation assays, with additional analysis of YAP nuclear translocation.\"},{\"question\":\"What mechanism connects TYRO3 activation to stemness induction?\",\"answer\":\"TYRO3 activation triggers YAP nuclear translocation. YAP knockdown suppressed the stemness-inducing effect, indicating the TYRO3/YAP signaling axis is responsible.\"}]","Targeting TYRO3 attenuates apoptotic cell-driven cancer stemness in triple negative breast cancer | PDF",1790082497,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6592277ee4ac34124ca9624ca0dd45c9.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8dfaa4dc2aa480a68c5665f04aed17d.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4048846792febedf5d9cc1decf3176da.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c48302694d119ce56ee4e021407ce07a.webp",980,1306]